- Home
- BOLT vs CLDI Comparison
BOLT vs CLDI Comparison
Compare BOLT & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- CLDI
- Stock Information
- Founded
- BOLT 2015
- CLDI 2014
- Country
- BOLT United States
- CLDI United States
- Employees
- BOLT N/A
- CLDI N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BOLT Health Care
- CLDI Health Care
- Exchange
- BOLT Nasdaq
- CLDI Nasdaq
- Market Cap
- BOLT 22.6M
- CLDI 18.1M
- IPO Year
- BOLT 2021
- CLDI N/A
- Fundamental
- Price
- BOLT $0.49
- CLDI $1.31
- Analyst Decision
- BOLT Hold
- CLDI Strong Buy
- Analyst Count
- BOLT 5
- CLDI 3
- Target Price
- BOLT $1.25
- CLDI $16.67
- AVG Volume (30 Days)
- BOLT 136.2K
- CLDI 1.8M
- Earning Date
- BOLT 03-20-2025
- CLDI 03-14-2025
- Dividend Yield
- BOLT N/A
- CLDI N/A
- EPS Growth
- BOLT N/A
- CLDI N/A
- EPS
- BOLT N/A
- CLDI N/A
- Revenue
- BOLT $9,779,000.00
- CLDI N/A
- Revenue This Year
- BOLT $9.87
- CLDI N/A
- Revenue Next Year
- BOLT N/A
- CLDI N/A
- P/E Ratio
- BOLT N/A
- CLDI N/A
- Revenue Growth
- BOLT 35.86
- CLDI N/A
- 52 Week Low
- BOLT $0.46
- CLDI $0.58
- 52 Week High
- BOLT $1.56
- CLDI $16.80
- Technical
- Relative Strength Index (RSI)
- BOLT 44.93
- CLDI 51.55
- Support Level
- BOLT $0.49
- CLDI $0.58
- Resistance Level
- BOLT $0.52
- CLDI $0.94
- Average True Range (ATR)
- BOLT 0.03
- CLDI 0.12
- MACD
- BOLT -0.00
- CLDI 0.03
- Stochastic Oscillator
- BOLT 24.24
- CLDI 83.93
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.